In our latest report, we explore the complexities of Amyotrophic Lateral Sclerosis (ALS), offering a comprehensive overview of the disease. From genetic components to the latest FDA-approved treatments, we cover the entire spectrum of ALS research and care.
Key highlights include:
- Overview of ALS demographics and societal impact
- Insights into the genetic causes of familial ALS and the role of specific gene mutations
- List of current treatments, including Qalsody, Relyvrio, Radicava, and more.
- Future prospects with ongoing clinical trials and experimental therapies.
- Information on Sano’s commitment to supporting individuals at risk of genetic ALS through Light the Way.
To learn more, download the report below!
